Literature DB >> 25533581

Management of fever and neutropenia in children with cancer.

A Vedi1, V Pennington, M O'Meara, K Stark, A Senner, P Hunstead, K Adnum, W Londall, L Maurice, Claire Wakefield, R J Cohn.   

Abstract

PURPOSE: Febrile neutropenia remains a common, life-threatening complication of chemotherapy in paediatric oncology. Delays in institution of empiric antibiotics have been identified at tertiary and regional centres caring for these patients and associated with decreased survival. Our objective was to reduce the time to administration of empiric antibiotics to less than 60 min from the time of presentation to hospital.
METHODS: A retrospective study of the records of oncology patients presenting to the emergency department of a tertiary hospital over a 3-month period was performed and time to first antibiotic administration recorded. Potential causes of delay in commencement of antibiotics were identified and an algorithm-based approach to the management of fever in immunocompromised children developed and implemented. Follow-up evaluation data were collected at 12 and 60 months post-intervention. Causes of delay in commencement of antibiotics at regional hospitals that share care with the tertiary hospital were identified through questionnaires, interviews and focus groups, involving patients and medical and nursing staff. The impact of the introduction of the algorithm at one peripheral hospital was evaluated.
RESULTS: The mean time to empiric antibiotics was reduced from 148 min (95% confidence interval (CI) 81-216) at baseline to 76 min (95% CI 50-101) at 12 months post-intervention and sustained at 65 min (95% CI 52-77) 5 years after the intervention. At the peripheral hospital, mean time to antibiotic delivery was reduced from 221 min (95% CI 114-328) to 65 min (95% CI 42-87) at 12 months after the intervention.
CONCLUSION: The introduction of the guideline, with teaching and support for staff and parents, resulted in an improvement in practice, meeting international guidelines and achieving sustained results at 5 years after introduction at a tertiary hospital. The guideline has been shown to be feasible and effective at a regional hospital.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25533581     DOI: 10.1007/s00520-014-2572-x

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  15 in total

1.  2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Authors:  Walter T Hughes; Donald Armstrong; Gerald P Bodey; Eric J Bow; Arthur E Brown; Thierry Calandra; Ronald Feld; Philip A Pizzo; Kenneth V I Rolston; Jerry L Shenep; Lowell S Young
Journal:  Clin Infect Dis       Date:  2002-02-13       Impact factor: 9.079

2.  Identification of educational and infrastructural barriers to prompt antibiotic delivery in febrile neutropenia: a quality improvement initiative.

Authors:  Erica Burry; Angela Punnett; Ashley Mehta; Jennifer Thull-Freedman; Lisa Robinson; Sumit Gupta
Journal:  Pediatr Blood Cancer       Date:  2011-12-06       Impact factor: 3.167

3.  Relation between the generation time and the lag time of bacterial growth kinetics.

Authors:  M L Delignette-Muller
Journal:  Int J Food Microbiol       Date:  1998-08-18       Impact factor: 5.277

4.  Length of stay and mortality associated with febrile neutropenia among children with cancer.

Authors:  Swati K Basu; Isabel D Fernandez; Susan G Fisher; Barbara L Asselin; Gary H Lyman
Journal:  J Clin Oncol       Date:  2005-11-01       Impact factor: 44.544

5.  Neutropenic fever: one institution's quality improvement project to decrease time from patient arrival to initiation of antibiotic therapy.

Authors:  Tammy Baltic; Evelyn Schlosser; Marilyn Kay Bedell
Journal:  Clin J Oncol Nurs       Date:  2002 Nov-Dec       Impact factor: 1.027

6.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Authors:  Alison G Freifeld; Eric J Bow; Kent A Sepkowitz; Michael J Boeckh; James I Ito; Craig A Mullen; Issam I Raad; Kenneth V Rolston; Jo-Anne H Young; John R Wingard
Journal:  Clin Infect Dis       Date:  2011-02-15       Impact factor: 9.079

7.  Emergency department waiting times for patients with cancer with febrile neutropenia: a pilot study.

Authors:  Anita Nirenberg; Lisa Mulhearn; Susan Lin; Elaine Larson
Journal:  Oncol Nurs Forum       Date:  2004-07-13       Impact factor: 2.172

8.  Antibiotics in 30 minutes or less for febrile neutropenic patients: a quality control measure in a new hospital.

Authors:  Amy L Corey; Stacy Snyder
Journal:  J Pediatr Oncol Nurs       Date:  2008-06-06       Impact factor: 1.636

9.  Parent attitudes to audio/visual telecommunications in childhood cancer: an Australian study.

Authors:  Belinda Goodenough; Richard J Cohn
Journal:  Telemed J E Health       Date:  2004       Impact factor: 3.536

10.  Low socioeconomic status is associated with prolonged times to assessment and treatment, sepsis and infectious death in pediatric fever in El Salvador.

Authors:  Ronald Gavidia; Soad L Fuentes; Roberto Vasquez; Miguel Bonilla; Marie-Chantal Ethier; Caroline Diorio; Miguela Caniza; Scott C Howard; Lillian Sung
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

View more
  2 in total

1.  Simple predictors of the re- occurrence of severe febrile neutropenia episode: a single-center retrospective cohort study in pediatric patients with malignant diseases.

Authors:  Silvije Šegulja; Alen Ružić; Dora Dujmić; Ksenija Baždarić; Jelena Roganović
Journal:  Croat Med J       Date:  2019-02-28       Impact factor: 2.415

2.  Use of biomarkers in the management of febrile neutropenia episodes in children with cancer.

Authors:  Benigna Maria de Oliveira
Journal:  Rev Bras Hematol Hemoter       Date:  2015-12-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.